doripenem has been researched along with Infections, Respiratory in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, CM; Chen, CC; Chuang, YC; Huang, HL; Lai, CC; Tang, HJ | 1 |
| Araki, N; Kamihira, S; Kohno, S; Morinaga, Y; Yamada, K; Yamada, Y; Yanagihara, K | 1 |
| Biedenbach, DJ; Fritsche, TR; Huynh, HK; Jones, RN; Sader, HS | 1 |
| Joseph, J; Rodvold, KA | 1 |
1 review(s) available for doripenem and Infections, Respiratory
| Article | Year |
|---|---|
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome | 2008 |
3 other study(ies) available for doripenem and Infections, Respiratory
| Article | Year |
|---|---|
Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Carbapenems; Cross Infection; Doripenem; Female; Hospital Mortality; Humans; Intraabdominal Infections; Male; Middle Aged; Respiratory Tract Infections; Retrospective Studies; Soft Tissue Infections; Tertiary Care Centers; Treatment Outcome; Urinary Tract Infections | 2016 |
In vivo efficacy of doripenem (DRPM) against Pseudomonas aeruginosa in murine chronic respiratory tract infection model.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Doripenem; Male; Meropenem; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Specific Pathogen-Free Organisms; Thienamycins | 2011 |
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Culture Media; Doripenem; Enterobacteriaceae; Enterococcus; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Quality Control; Respiratory Tract Infections | 2004 |